OnabotulinumtoxinA is an effective minimally invasive option for patients with PP, as measured by both clinician- and patient ...

The FDA withdrew a proposed rule from 2015 that would have banned minors from using tanning beds nationwide, despite known skin cancer risks.

An increasing number of Americans stopped, modified, or struggled to pay for their health insurance following the end of ...

Female cancer patients have increased survival but also have a higher risk for serious and adverse side effects from cancer ...

Patients with alopecia areata who did not respond to initial treatment with a JAKi or who did not maintain response may ...

Vitamin D3 did not affect COVID-19-related health care outcomes at 4 weeks but may have contributed to a reduction in long ...

Immunosuppressive disease is independently associated with significantly shorter survival among patients with CSCC receiving ICI therapy.

Ivarmacitinib is associated with favorable treatment outcomes in patients with moderate to severe AD across subgroups with diverse characteristics.

Oral TYK2 inhibitor deucravacitinib receives FDA approval for active psoriatic arthritis based on significantly improved ...

Results of a national sample reveal that more than 82 million Americans made at least 1 trade-off in the past year to pay for health care.

For children with atopic dermatitis (AD), dupilumab treatment restores skin barrier function, according to a study published ...

Appropriate use of immune checkpoint inhibitors and immunotherapy differs in adults with unresectable, metastatic cutaneous ...